| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |